EFFECTIVENESS OF OUTPATIENT TREATMENT OF PELVIC INFLAMMATORY DISEASE (PID)

盆腔炎症性疾病 (PID) 门诊治疗的有效性

• 批准号: 6280084
• 负责人: David E Soper
• 金额: $ 2.73万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6280084
• 关键词: antibacterial agents; chemoprevention; clinical research; clinical trials; combination chemotherapy; drug administration rate /duration; drug screening /evaluation; female; fertility; health care cost /financing; human subject; human therapy evaluation; microorganism disease chemotherapy; nutrition related tag; oral administration; outpatient care; parenteral feedings; pelvic inflammatory disease; probenecid; reproductive system disorder chemotherapy; women's health

The primary aims of this study are to test the effectiveness and cost- effective-ness of outpatient versus inpatient treatment for pelvic inflammatory disease in preventing involuntary infertility. Randomization will be to either outpatient single dose of parenteral cefoxitin with probenecid, followed by oral doxycycline for 14 days or inpatient parenteral cefoxitin and doxycycline for at least 48 hours, followed by oral doxycycline to complete a 14 day course. This multi-center study is sponsored by the AHCPR under the NIH.

这项研究的主要目的是测试有效性和成本 - 骨盆的门诊与住院治疗的有效性 预防非自愿不孕症的炎症性疾病。 随机化 将是在门诊单剂量的单剂量 概率，然后是口服强力霉素14天或住院 肠胃外的头孢辛蛋白和强力霉素至少48小时，其次是 口服强力霉素完成14天的课程。 这项多中心研究是 由NIH下的AHCPR赞助。